CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Bayer AG Company Snapshot
Bayer AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bayer AG with three other pharmaceutical manufacturers in Europe: Novartis AG of Switzerland (2016 sales of 48.88 billion Swiss Francs [US$50.28 billion] of which 66% was innovative medicines), Sanofi S.A. of France (34.71 billion Euro [US$38.91 billion] of which 84% was Pharmaceuticals), and Roche Holding Aktiengesellschaft which is based in Switzerland (50.58 billion Swiss Francs [US$52.03 billion] of which 77% was Pharmaceuticals).

Sales Analysis. Bayer AG reported sales of 46.77 billion Euro (US$52.43 billion) for the year ending December of 2016. This represents a very small increase of 1.0% versus 2015, when the company's sales were 46.32 billion Euro. Sales at Bayer AG have increased during each of the previous five years (and since 2011, sales have increased a total of 28%). Sales of Reconciliations saw an increase that was more than double the company's growth rate: sales were up 50.0% in 2016, from 4.00 million Euro to 6.00 million Euro. Bayer AG also saw significant increases in sales in Pharmaceuticals and Biological Products (up 19.5% to 16.42 billion Euro) . Not all segments of Bayer AG experienced an increase in sales in 2016: sales of Consumer Care fell 33.9% to 6.04 billion Euro. Bayer AG also experienced decreases in sales in Cropscience (down 4.4% to 9.92 billion Euro) and All Other Segments (down 5.0% to 1.04 billion Euro) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Bayer AG
  Stock Performance Chart for Bayer AG
 
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 116.95
(Figures in Euro)
1 Week 0.2%   13 Weeks 11.2%  
4 Weeks 9.8%   52 Weeks 30.6%  
 
Bayer AG Key Data:
  Ticker: BAYN Country: Germany
  Exchanges: NYSE AMS BRU DUS FRA GVA LON PAR TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 46,769,000,000
(Year Ending Jan 2017).
Employees: 115,200
  Currency: Euro Market Cap: 96,711,546,146
  Fiscal Yr Ends: December Shares Outstanding: 826,947,808
  Share Type: Stammaktie Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.